Get notified when MDXH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Immediate Dilution of $1.36 Per Ordinary Share (new) — New investors pay $0.454 per share but receive net tangible book value of negative $0.91 per share, resulting in immediate and substantial dilution.
MDxHealth prices $20M registered direct offering of 44.05M shares at $0.454
Filed August 13, 2026 · ~1 min read
Key Changes
-
high
MDxHealth is selling 44,052,862 ordinary shares at $0.454 per share in a registered direct offering, expecting approximately $20 million in gross proceeds before expenses.
The Offering verify on EDGAR → -
high
The company estimates net proceeds of approximately $20 million, after deducting about $200,000 in offering expenses, to be used for general corporate purposes, product development, and commercialization expansion.
Use of Proceeds verify on EDGAR → -
high
Investors will experience immediate dilution of $1.36 per share, as the offering price exceeds the as-adjusted net tangible book value of negative $0.91 per share.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MLKN 10-Q) is open in full — no account needed.
Partner
Trade MDXH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify